Ahmed Saad Abdlkadir

ORCID: 0000-0002-2009-5110
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Treatment and Research
  • Radiopharmaceutical Chemistry and Applications
  • Peptidase Inhibition and Analysis
  • Neuroendocrine Tumor Research Advances
  • Medical Imaging Techniques and Applications
  • Thyroid Cancer Diagnosis and Treatment
  • Protease and Inhibitor Mechanisms
  • Medical Imaging and Pathology Studies
  • Head and Neck Cancer Studies
  • Cancer, Lipids, and Metabolism
  • Cardiac Structural Anomalies and Repair
  • Radiomics and Machine Learning in Medical Imaging
  • Lung Cancer Treatments and Mutations
  • BRCA gene mutations in cancer
  • CAR-T cell therapy research
  • Cancer Diagnosis and Treatment
  • Uterine Myomas and Treatments
  • Bone and Joint Diseases
  • Lymphoma Diagnosis and Treatment
  • Endometriosis Research and Treatment
  • Prostate Cancer Diagnosis and Treatment
  • Hematological disorders and diagnostics
  • Endometrial and Cervical Cancer Treatments
  • Advancements in Semiconductor Devices and Circuit Design
  • HER2/EGFR in Cancer Research

King Hussein Cancer Center
2022-2025

Royal London Hospital
2023

Baghdad Medical City
2023

University of Jordan
2023

Background/Objectives: Over the past four years, 68Ga-fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography (PET/CT) has been established at a tertiary cancer care facility in Jordan. This retrospective study aims to explore tracer uptake metrics across various epithelial neoplasms, identify diagnostic pitfalls associated with 68Ga-FAPI PET/CT, and evaluate influence of PET/CT staging results on changes therapeutic intent compared gold standard...

10.3390/diagnostics15020218 article EN cc-by Diagnostics 2025-01-19

Background/Objectives: This study evaluates the diagnostic accuracy of [18F]fluorodeoxyglucose ([18F]FDG) positron emission tomography (PET) using bone marrow biopsy (BMB) and clinical follow-up as reference standards. It further identifies predictive factors for involvement (BMI) in non-Hodgkin lymphoma (NHL) patients. Methods: NHL patients who underwent [18F]FDG PET BMB at diagnosis a tertiary cancer center were included this study. Diagnostic was analyzed, logistic regression performed to...

10.3390/cancers17020231 article EN Cancers 2025-01-13

The objective of this retrospective study is to assess the effectiveness and safety two beta-emitting prostate-specific membrane antigen (PSMA) radioligands, [177Lu]Lu [161Tb]Tb, in heavily treated patients with metastatic castration-resistant prostate cancer (mCRPC). A total 148 cycles PSMA radioligand therapy were given 53 at a specialized care center Amman, Jordan. This treatment was offered following exhaustion all prior modalities. Approximately half cases (n = 26) demonstrated an...

10.3390/cancers16111974 article EN Cancers 2024-05-23

DTC accounts for the majority of endocrine tumors. While incidence thyroid cancer has been increasing globally over past few decades, papillary carcinoma (PTC) generally shows an excellent prognosis, except in cases with aggressive clinicopathological features. This study aimed to assess 5- and 10-year overall survival (OS) progression-free (PFS) 528 Arabic patients diagnosed primary from 1998 2021. Additionally, analyze impact various factors on both OS PFS. An univariable analysis was...

10.3390/cancers15164102 article EN Cancers 2023-08-15

Abstract 68 Ga-FAPI has been introduced recently in many nuclear medicine centers. Many pitfalls have discussed previously. However, not all are currently addressed the literature. To our knowledge, this is first reported case to address nonspecific expression at anorectal sphincter. A 69-year-old woman was diagnosed with intrahepatic cholangiocarcinoma. scan performed after diagnostic workup and chemoradiotherapy. In addition Ga-FAPI–avid lesion primary site, several nononcological...

10.1097/rlu.0000000000004802 article EN Clinical Nuclear Medicine 2023-09-21

Pediatric Differentiated Thyroid Cancer (pedDTC) is a rare pediatric malignancy with an increasing incidence over time. To date, there paucity of literature specifically addressing pedDTC within the context Middle Eastern ethnicity. This retrospective study aimed to assess risk-stratifying factors for overall survival (OS) and event-free (EFS) in DTC patients from Iraq Jordan. The medical records 81 two tertiary cancer institutes were retrieved. Kaplan–Meier analysis was employed investigate...

10.3390/life14010158 article EN cc-by Life 2024-01-22

Abstract Aim The integration of innovative radio-pharmaceutical agents targeting prostate-specific membrane antigen (PSMA) within nuclear medicine has transformed prostate cancer detection and management. This study aims to investigate the present landscape [177Lu]Lu-PSMA in cancer, elucidating trends, global contributions, scholarly outlets, institutions, thematic concentrations with an aim inform forthcoming research endeavors. Methods We systematically probed Scopus repository for...

10.1055/a-2221-3036 article EN Nuklearmedizin - NuclearMedicine 2024-01-23

Abstract Cerebral and muscular metastases from prostatic adenocarcinoma occur rarely. Patients who develop such metastatic pattern exhibit noticeable symptoms. Herein, we present a 68-year-old man diagnosed with castrate-resistant prostate cancer. The patient received multiple 177 Lu-PSMA cycles. After the last cycle, posttreatment SPECT/CT suggested disease progression uncommon in right temporal brain lobe muscles. 68 Ga-PSMA PET/CT MRI confirmed these findings. Surprisingly, remained...

10.1097/rlu.0000000000005050 article EN Clinical Nuclear Medicine 2024-01-24

This study aims to determine the diagnostic accuracy of staging PET/CT and neck MRI in patients with laryngeal carcinoma assess value predicting progression-free survival (PFS) overall (OS). Sixty-eight who had both modalities performed before treatment between 2014 2021 were included this study. The sensitivity specificity evaluated. 93.8% sensitivity, 58.3% specificity, 75% for nodal metastasis, whereas 68.8%, 61.1%, 64.7% accuracy, respectively. At a median follow-up 51 months, 23...

10.3390/jcm12103514 article EN Journal of Clinical Medicine 2023-05-17

Since its inception in 2012, the Nuclear Medicine Global Initiative (NMGI) of Society and Molecular Imaging has played an important role addressing significant challenges field nuclear medicine molecular imaging. The first 3 projects were dedicated to standardizing pediatric practices, global radionuclide access availability, assessing educational training initiatives on theranostics across globe. These efforts aimed advance human health, foster worldwide collaboration, standardize...

10.2967/jnumed.124.269215 article EN Journal of Nuclear Medicine 2025-03-27

2-Deoxy-2-[ 18 F]fluoro- d -glucose PET/computed tomography ([ F]FDG PET/CT) has proven to be a sensitive method for the detection and evaluation of hematologic malignancies, especially lymphoma. The increasing incidence mortality rates leukemia have raised significant concerns. Through utilization whole-body imaging, [ PET/CT provides thorough assessment entire bone marrow, complementing limited insights provided by biopsy samples. In this regard, ability assess diverse types been found...

10.1097/mnm.0000000000001846 article EN Nuclear Medicine Communications 2024-04-22
Coming Soon ...